ENDOCRINOLOGY BOARD REVIEW - PowerPoint PPT Presentation

1 / 46
About This Presentation
Title:

ENDOCRINOLOGY BOARD REVIEW

Description:

ENDOCRINOLOGY BOARD REVIEW THYROID DISORDERS Henri Godbold, MD General - Thyroid produces two related hormones thyroxine(T4) and triidothyronine (T3) - Function is ... – PowerPoint PPT presentation

Number of Views:340
Avg rating:3.0/5.0
Slides: 47
Provided by: henri257
Category:

less

Transcript and Presenter's Notes

Title: ENDOCRINOLOGY BOARD REVIEW


1
ENDOCRINOLOGYBOARD REVIEW
  • THYROID DISORDERS
  • Henri Godbold, MD

2
General
  • - Thyroid produces two related hormones
    thyroxine(T4) and triidothyronine (T3)
  • - Function is through nuclear receptors playing
    a role in cell differentiation
  • - Maintains thermogensis, and metabolic
    homeostasis
  • - Disorders result from autoimmune processes
    that either stimulate overproduction of hormones
    (thyrotoxicosis) or glandular destruction and
    hormone deficiency (hypothyroidism)
  • - Benign nodules and various forms of thyroid
    cancers

3
Anatomy
  • - Located anterior to trachea consist two lobes
  • -  Weighs 12-20gm soft and highly vascular a
    posterior region gland contain four parathyroid
    gland that produce parathyroid hormone
  • - Lateral borders of the gland is transversed by
    the recurrent laryngeal nerves
  • - Develops from the floor of the primitive
    pharynx third week of gestation migrates from the
    foramen cecum, at the base of tongue along the
    thyroglossal duct to neck
  • - Hormonal synthesis usually begin at about 11
    weeks gestation

4
Thyroid Physiology
  • - Thyroid releases (2) forms of hormones
  • - Thyroxine (T4) and triiodothyroxine (T3) ratio
    141
  • - T3 is 80 derived from peripheral tissue
  • - T4 all within the thyroid gland
  • - T3 is produced from T4 in liver, kidneys,
    pituitary gland and CNS
  • - T3 is the physiologically active in almost all
    tissue binding to specific nuclear
    receptors regulating the transcription of thyroid
    hormone dependent genes
  •  

5
(No Transcript)
6
(No Transcript)
7
Drugs decreasing Peripheral conversion of T4 to
T3
  •        Propranolol
  •        Corticosteroids
  •        Propylthiouracil (PTU)
  •        Amiodarone
  •  

8
SYNTHESIS AND RELEASE
9
  • - TSH controls release under the influence TRH
  • from the hypothalamus
  • - TSH stimulate thyrocyte function resulting in
  • iodide uptake actively on the basal surface
    of the
  • thyroid follicle cell
  • - Iodide undergoes oxidation to iodine which
  • iodinates tyrosine residues catalyzed by
  • peroxidase
  • - Thyroglobulin coupling occurs to form mono-
  • and diiodotyrosine (MIT and DIT
  • - Two DITs coupling T4
  • - One DIT and one MIT combine T3
  • - If iodine scarce, the production of T3 is
    increase
  • - Activity is dictated by iodines attached
  • to tyrosine molecules and location
  •  

10
(No Transcript)
11
(No Transcript)
12
Secretion
  • Degradation process with endocytosis of the
    follicular colloid containing MIT, T3,
  • T4, DIT attached to thyroglobulin undergoes
    fusion with lyosome resulting in proteolysis
    release
  • Deiodination occurs with the recycling iodide and
    secretion of T3 and T4
  • Circulating thyroid hormones are more than 99
    protein bound, are thyroxine-binding globulin,
    albumin, and transthyretin.
  • 80 of circulating T3 is derived from the
    conversion of T4 outside the thyroid
  • Serum half-life of T3 is much shorter than that
    T4 (1day vs 8days)

13
(No Transcript)
14
Storage
  • - Iodine as iodinated tyrosine of
  • thyroglobins 8000 micrograms total
  • - T4 and T3 represent 600 micrograms
  • each
  • - Enough hormone is stored in the
  • follicular colloid to last 2-3 months 

15
(No Transcript)
16
Overveiw of Thyroid Fx Workup
1st Test 2nd Test 3rd Test
TSH FT4-I, FT4 Clinical Status
HIGH Low Prim hypothyrism N/A
HIGH Normal Subclinical hypothyism TRH to confirm
HIGH High Pituitary hyperthyrism N/A
LOW High Thyrotoxicosis RAIU
LOW Normal Subclinical hypothyrism TRH to confirm
LOW Low Pituitary hyperthyrism N/A
17
Measurement RAIU
Levels Specific disorders
High Hyperfunction (Graves, multinodule goiter, toxic solitary nodule, hCG secreting tumor)
Normal Euthyroid
Low Thyroiditis, severe iodine excess, amiodarone induced thyrotoxicosis
18
Drugs and condition that affect thyroid Function
Tests
19
Increase TBG Decrease TBG Block peripheral conversion of T4 to T3 Blocks thyroidal release T4 and T3
Estrogen OCT, pregnancy Tamoxifen Clofibarate Narcotics Hepatitis Bililary cirrhosis Androgens Gluccorticoid Nephrotic syn Propranolol Glucorticoid PTU Amiodarone Lithium Iodine
20
Thyroid Pathology
  • A. Thyroid Gland
  • 1. Multinodular goiter (nontoxic goiter)
    Presentation
  • i. Females gt males
  • ii. Frequently asymptornatic
  • iii. Typically euthyroid
  • iv. Goiter
  • v. Plummer's syndromedevelopment of
  • hyperthyroidism (toxic multinodular Goiter)
  • late in course

21
  • B. GROSS
  • enlarged thyroid gland with multiple colloid
    nodules
  • C. MICROSCOPIC
  • i. Nodules of varying sizes composed of colloid
    follicles
  • ii. Calcification, hemorrhage, cystic
    degeneration, and fibrosis
  • D. LAB normal T4, T3, and TSH

22
  • B Hyperthyroidism
  • 1. General features of hyperthyroidism I
  • a. Clinical features
  • i. Tachycardia and palpitations
  • ii. Nervousness and diaphoresis
  • iii. Heat intolerance
  • iv. Weakness and tremors
  • v. Diarrhea
  • vi. Weight loss despite a good appetite
  • b. Labs
  • i. Elevated free T4
    ii. Primary
    hyperthyroidism decreased TSH

23
  • Graves'disease
  • a. Definition autoimmune diseases
    characterized by production of IgG
    autoantibodies to the TSH receptor
  • b. Clinical features
  • i. Females gt males age 20-40
  • ii. Hyperthyroidism
  • iii. Diffuse goiter
  • iv. Ophthalmopathy exophthalmus
  • v. Dermopathy pretibial myxcdema
  • c. Micro hyperplastic follicles with
    scalloped
  • colloid

24
  • Other causes of hyperthyroidism
  • a. Toxic multinodular goiter
  • b. Toxic adenoma functioning adenoma
  • producing thyroid hormone
  • c. Hashimotos and subacute thyroiditis
  • (transient hyperthyroidism)

25
Juvenile Graves Disease
  • Diffuse hyperplasia
  • Most common cause of thyrotoxicosis in children
    and adolescents
  • Clinical manifestation
  • - muscle weakness - behavior
    problems
  • - anxiety -
    cardiomegaly
  • - palpitations -
    tachycardia
  • - appetite -
    widen pulse pressure
  • - Tremor -
    Emotional liability
  • - rapid DTR time - Excessive
    perspiration
  • Opthalmopathy, dermopathy, pretibial myxedema
  • rare in children

26
  • Test TSH suppressed and serum T4 high
  • Treatment
  • a. Blunting toxic effects circulating T3/T4
  • b. Stop further increase in production
  • B-blockers prior to Sx intervention
  • RAI rarely used in children and adolescences
    potential risk leukemia, thyroid Ca, and genetic
    disorder.
  • Medical management PTU and methimazole
  • mechanism Both inhibit the coupling of
  • iodotyrosines,
    oxidation and
  • binding of iodide

27
  • PTU 5-10mg/kg PO div q8hr
  • Methimazole 0.2 mg/kg PO daily
  • Once gland cools off and decrease in size
  • tapper drugs
  • Give synthetic T4 once euthyroid adjust to
    maintain a euthyroid status

28
Neonatal Thyrotoxicosis
  • Due to TSH-receptor stimulating antibodies(TSH)
  • Transmitted transplacentally in mother with
  • inactive or active Graves or Hashimoto
    thyroiditis
  • Presentation newborn irritability, flushing,
    tachycardia, HTN, thyromegaly
  • High total T4, FT4, T3 postnatal blood, low TSH
  • Treatment
  • a. sedative and digitalis if needed
  • b. Iodide
  • c. Lugol (5 iodine and 10 K iodine)
  • d. Methimazole

29
Hypothyroidism
  • a. Clinical features
  • i. Fatigue
  • ii. Sensitivity to cold temperatures
  • iii. Decreased cardiac output
  • iv. Myxedema
  • - Facial and periorbital edema
  • - Peripheral edema of the hands and
  • feet
  • - Deep voice
  • - Macroglossia
  • v. Constipation
  • vi. Anovulatory cycles


30
  • b. Lab
  • i. Decrease Free T4
  • ii. Primary hypothyroidism elevated TSH
  • Iatrogenic hypothyroidism
  • Most common cause of hypothyroids in US
  • Secondary to thyroidectomy or RAI rx
  • Rx Levothyroxine 12.5-50mcg PO qd adjusting
  • dose by 12.5-25mcg/d q4-8wks

31
Congential Hypothyroidism(cretinism)
  • a. Etiology
  • i. Endemic region iodine deficiency during
    intrauterine and
  • neonatal life ( worldwide)
  • ii. Non endemic regions thyroid dysgenesis
  • b. Presentation
  • i. Failure to thrive
  • ii. Stunted bone growth and dwarfism
  • -Commonly absent distal femoral epiphysis
  • iii. Spasticity and motor incoordination
  • iv. Mental retardation
  • v. Goiter (endemic cretinism)
  • - Endemic goiter
  • a. Uncommon in the US
  • b. Etiology dietary deficiency of iodine

32
Clinical Manifestation congenital Hypothyroidism
  • Occurs in 1/4000 Worldwide
  • Most infant are asymptomatic at birth because of
    transplacental passage of T4 (usu 3rd day of
    life)
  • Most common cause is thyroid dysgenesis
  • Presentation hypoglycemia, jaundice
  • micropenis, midline
    facial
  • anomalies, enlarge
    posterior
  • fontanelle, macroglossia
  • Rx Initial dose Sodium L-tyroxine 10-15
  • microgrms/kg/day( should not be mixed soy
  • protien or iron) Then, 4 micrgms/kg/day

33
Thyroiditis
  • Hashimoto's thyroiditis
  • a. Definition chronic autoimmune disease
    characterized by immune destruction of
    the thyroid gland and hypothyroidism
  • b. Most common noniatrogenic cause of
    hypothyroidism and Goiter in children gt 6yo and
    adults in US
  • c. Clinical presentation
  • i. Females gt males age 40-65
  • ii. Painless goiter
  • iii. Hypothyroid
  • iv. Initial inflammation may cause transient
    hyperthyroidism.
  • d. Gross pale enlarge gland
  • e. Micro
  • i. Lymphocytic inflammation with
    germinal centers
  • ii. Epithelial "Harthle cell" changes
  • f. May be associated with other autoimmune
    diseases (SLE, RA, SS Sjogren's syndrome,
    etc.)
  • g. Complication increased risk of non-Hodgkin
    lymphoma (NHL) B-cell lymphoma

34
  • 2. Subacute thyroiditis
  • a. Synonyms De Quervain's thyroiditis,
    granulomatous
  • thyroiditis
  • b. Clinical features
  • i. Second most common form of
    thyroiditis
  • ii. Females gt males age 30-50
  • iii. Preceded by a viral illness
  • iv. Tender, firm, enlarged thyroid gland
  • v. May have transient hyperthyroidism
  • c. Micro granulomatous thyroiditis
  • d. Prognosis typically the disease follows a
    self-limited course
  • e. Symptoms control with analgesics,
    prednisone very severe dx

35
  • Riedel's thyroiditis
  • a. Definition rare disease of unknown etiology
    characterized by destruction of the thyroid gland
    by dense fibrosis and fibrosis of surrounding
    structures (trachea and esophagus)
  • b. Clinical features
  • i. Females gt males middle age
  • ii. Irregular, hard thyroid that is adherent to
    adjacent structures
  • iii. May mimic carcinoma and present with
    stridor, dyspnea, or dysphagia
  • c. Micro
  • i. Dense fibrous replacement of the thyroid
    gland
  • ii. Chronic inflammation
  • d. Associated with retroperitoneal
    and mediastinal fibrosis

36
Thyroid Neoplasia
  • Adenomas
  • a. Follicular adenomas are the most common
  • b. Clinical features
  • i. Usually painless, solitary nodules
  • In first 20 yrs life likely
    malignant than older person
  • ii. "Cold nodule" on thyroid scans
  • iii. May be functional and cause
    hyperthyroidism
  • (toxic adenoma)
  • 2. Papillary carcinoma
  • a. Epidemiology
  • i. Account for 80 of malignant thyroid
    tumors
  • ii. Females gt males age 20-50
  • iii. Risk factor radiation
    exposure
  • b. Micro
  • i. The tumor typically exhibits a papillary
    pattern.
  • ii. Occasional psammoma bodies
  • iii. Characteristic nuclear features Clear
    "Orphan Annie eye" nuclei Nuclear grooves

37
  • Intranuclear cytoplasmic inclusions
  • c. Lymphatic spread to cervical nodes is common.
  • d. Treatment
  • i. Resection is curative in most cases.
  • ii. Radiotherapy with iodine 131 is effective
    for metastases.
  • e. Prognosis excellent 20-year survival 90
  • Follicular carcinoma
  • a. Accounts for 15 of malignant thyroid tumors
  • b. Females gt males age 40-60
  • c. Hematogenous metastasis to the bones or lungs
    is common.
  • d. High mortality rate because most present with
    distant mets

38
  • Medullary carcinoma
  • a. Accounts for 5 of malignant thyroid tumors
  • b. Arises from C cells (parafollicular cells)
    and secretes
  • calcitonin
  • c. Micro nests of polygonal cells in an amyloid
    stroma
  • d. Minority (25) are associated with MEN 2 and
    MEN
  • 3 syndromes
  • Treatment primarily surgical
  • - Advance disease external RT and chemo

39
  • Anaplastic carcinoma
  • a. Presentation
  • i. Females gt males age gt 60
  • ii. Firm, enlarging, bulky mass
  • iii. Dyspnea and dysphagia
  • iv. Tendency for early widespread
  • metastasis and invasion
    of the
  • trachea and esophagus
  • b. Micro undifferentiated, anaplastic, and
  • pleornorphic cells
  • c. Prognosis very aggressive and rapidly
    fatal

40
Diagnosis
  • Fine needle aspirate vs. excision
  • - Hx RT to neck or head
  • - rapidly growing nodule
  • - satellite LN and/or distant mets
  • - Hoarseness or dysphagia
  • Rx Well differentiated neoplasm should be
    excised
  • - TSH suppression
  • - RAI ablation

41
(No Transcript)
42
  • Q1 An 18yo old boy presents with a 1 month
    history of slowly enlarging neck mass. You
    palpate a 2-cm mass in the superior lobe of the
    rt. thyroid with no lymphadenopathy.
  • Of the following, the BEST next step is to
  • Begin therapy with RAI
  • Obtain anteroposterior and lateral CXR
  • Perform needle bx of the neck
  • Perform total thyroidectomy
  • Prescribe oral cephalexin

43
  • Q2. 15yo female presents with an asymptomatic
    goiter. She has type 1 diabetes that was
    diagnosed at age 7 years
  • Of the following, study that is MOST likely to
    establish the diagnosis is
  • Measurement of antiperoxidase antibodies
  • Needle bx of thyroid
  • Technetium thyroid scan
  • Thyroid-binding globulin levels
  • US of the thyroid

44
  • Q3. 44yo male involved in a MVA unresponsive
    intubated in ICU with multiple orthropedic
    injuries. He is stabilized medically on day 2
    undergoes open reduction and internal fixation of
    right femur and right humerus. After returning to
    the ICU, his TSH is 0.3mU/L and total T4 is
    normal. T3 is 0.6 micrograms/dl. What is the next
    appropriate step in the management of this
    patient?
  • Start levothyroxine
  • RAIU scan
  • Thyroid US
  • Observe patient
  • Initiate prednisone

45
  • Q4. Which of the following statements regarding
    hypothyroidism is true?
  • Hashimotos thyroiditis is the most common cause
    of hypothyroidism worldwide
  • The annual risk of developing overt clinical
    hypothyroidism from subclinical hypothyroidism in
    patients with positive thyroid peroxidase
    antibodies is 20.
  • Hashimotos is characterized by marked
    infiltration of thyroid with activated T and B
    cells
  • Low TSH excludes the diagnosis of hypothyroidism
  • Thyroid peroxidase antibodies are present in 50
    of patients with autoimmune hypothyroidism

46
References
  • American College of Physicians
  • MKSAP 13
  • MedStudy Pediatric Board Review
  • Harrisons Principle of Internal Medicine
Write a Comment
User Comments (0)
About PowerShow.com